Related Experiment Video
Updated: Sep 26, 2025

Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
How can we interpret the relationship between liquid-liquid phase separation and amyotrophic lateral sclerosis?
Kohsuke Kanekura1, Masahiko Kuroda2
1Department of Molecular Pathology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. kanekura@tokyo-med.ac.jp.
Neurodegenerative diseases involve protein aggregates, like those in ALS/FTD. Liquid-liquid phase separation (LLPS) of proteins such as TDP-43 and FUS may drive disease pathogenesis and offers therapeutic targets.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Neurodegenerative diseases are characterized by insoluble intracellular protein aggregates.
- These aggregates, found in diseases like Alzheimer's and ALS, are ubiquitinated and resistant to detergents, suggesting misfolding.
- The precise molecular mechanisms driving inclusion body formation remain largely unknown.
Purpose of the Study:
- To explore the role of liquid-liquid phase separation (LLPS) in the pathogenesis of neurodegenerative diseases.
- To discuss the relationship between LLPS in ALS-associated proteins and disease mechanisms.
- To outline potential therapeutic strategies targeting LLPS.
Main Methods:
- Review of existing literature on protein aggregation and LLPS in neurodegenerative diseases.
- Focus on specific proteins like TDP-43 and FUS implicated in ALS and FTD.
- Analysis of the transition from liquid to solid phases in protein condensates.
Main Results:
- Proteins linked to ALS/FTD, including TDP-43 and FUS, undergo LLPS.
- LLPS can lead to increased local protein concentration and subsequent liquid-solid phase transitions.
- Sequestration of essential proteins within LLPS droplets or altered phase behavior can impair neuronal function.
Conclusions:
- LLPS is a critical factor in the pathogenesis of neurodegenerative diseases.
- Understanding LLPS mechanisms in proteins like TDP-43 and FUS is key to disease insight.
- Targeting LLPS presents a promising avenue for developing novel therapeutics for neurodegenerative conditions.
More Related Videos
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
09:36Primary Cultures of Rat Astrocytes and Microglia and Their Use in the Study of Amyotrophic Lateral Sclerosis
Published on: June 23, 2022
Related Concept Videos
Cross-bridge Cycle
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Lysosomal Hydrolases